SGN-1

N/A

Report date: 2024/01/31 17:13:18

Base Information

Drug NameSGN-1
Drug Alias NameOncolytic bacteria SGN-1Genetically modified Salmonella comprising of methioninase SGN-1桑美威克SalMet-VecSGN-1
ClassificationNatural product/Extract > Microbial extractBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacements
TargetsNot applicable
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwanMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesGuangzhou Sinogen Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesGuangzhou Sinogen Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A